Goldmann L, Duan R, Kragh T, Et Al. Oral Bruton Tyrosine Kinase Inhibitors Block Activation of the Platelet Fc Receptor CD32a (FcγRIIA): A New Option in HIT? Blood Adv. 2019;3(23):4021-4033.
Blood advances - United States
doi 10.1182/bloodadvances.2019001362
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 7, 2020
Authors
Unknown
Publisher
American Society of Hematology